Flexion Therapeutics to Report First-Quarter 2020 Financial Results on May 7, 2020
April 30 2020 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it
will report its first-quarter 2020 financial results after the
close of the U.S. financial markets on Thursday, May 7, 2020.
Flexion’s management will host a conference call at 4:30 p.m. ET to
discuss the results and provide an update on business
operations.
A live webcast of the conference call can be
accessed through the “Investors” tab on the Flexion Therapeutics
website, and a replay will be available online after the call. For
those planning to ask a question, the dial-in number for the
conference call is 855-770-0022 for domestic participants and
908-982-4677 for international participants, with Conference ID #
4498458. Please dial in at least 15 minutes in advance to ensure a
timely connection to the call.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical
company focused on the development and commercialization of novel,
local therapies for the treatment of patients with musculoskeletal
conditions, beginning with osteoarthritis, the most common form of
arthritis. The Company's core values are focus, ingenuity,
tenacity, transparency and fun. Visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate
Communications & Investor RelationsT:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Sep 2023 to Sep 2024